Montoya-Suarez, J. L., Zagorac, I., Fernandez-Gaitero, S., Penning, R., Post, H., Bueno, M. J., . . . Apala, J. V. (2018). In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
Citación estilo ChicagoMontoya-Suarez, José Luis, et al. In Vivo Phosphoproteomics Reveals Kinase Activity Profiles That Predict Treatment Outcome in Triple-negative Breast Cancer. 2018.
Cita MLAMontoya-Suarez, José Luis, et al. In Vivo Phosphoproteomics Reveals Kinase Activity Profiles That Predict Treatment Outcome in Triple-negative Breast Cancer. 2018.
Precaución: Estas citas no son 100% exactas.